Emergent Biosolutions Inc: Rising -89.92% from 52-Week Low, Can the Stock Stay Afloat?

Emergent Biosolutions Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $16.66 on 02/21/23, while the lowest value for the same period was recorded at $1.42 on 02/06/24.

52-week price history of EBS Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Emergent Biosolutions Inc’s current trading price is -89.92% away from its 52-week high, while its distance from the 52-week low is 18.31%. The stock’s price range during the 52-week period has remained between $1.42 and $16.66. In the Healthcare sector, the company’s shares saw a trading volume of around 1.24 million for the day, which was evidently lower than the average daily volume of 1.34 million over the past three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Market Capitalization and Financial Performance: An In-Depth Look

Emergent Biosolutions Inc (EBS) has experienced a quarterly decline of -28.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 87.16M and boasts a workforce of 2500 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3428, with a change in price of -2.2900. Similarly, Emergent Biosolutions Inc recorded 1,404,320 in trading volume during the last 100 days, posting a change of -57.68%.

Examining EBS’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for EBS stands at 1.26. Similarly, the long-term debt-to-equity ratio is also 0.66.

EBS Stock Stochastic Average

Emergent Biosolutions Inc’s raw stochastic average for the past 50 days is presently 19.40%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 31.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.41% and 11.97%, respectively.

EBS Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -30.00%. However, over the last six months, the performance has been stronger by -71.62%. The price of EBS decreased -19.23% over the last 30 days. And in the last five days, it has surged by 1.82%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts